Physician profile
Devin Williams
NPI 1548797715
$4,130.28
in general payments reported to CMS, 2019-2025
19 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2020: $20.34 · 2021: $214 · 2022: $841 · 2023: $1,820 · 2024: $17.09 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,133 · Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,133.18 |
| Food and Beverage | $857.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,738.51 | 2019-2025 | Dailies Aqua Comfort Plus, Air Optix, Dailies Total1 Multifocal |
| Sun Pharmaceutical Industries INC. | $489.48 | 2021-2023 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $464.49 | 2019 | |
| Biotissue Holdings INC. | $222.83 | 2021-2023 | |
| Johnson & Johnson Vision Care, INC. | $187.16 | 2019-2025 | |
| Oyster Point Pharma, INC. | $169.52 | 2022 | |
| Alimera Sciences, INC. | $163.69 | 2019 | |
| Allergan, INC. | $145.76 | 2021 | |
| Abbvie INC. | $142.55 | 2022 | |
| Aerie Pharmaceuticals, INC. | $141.27 | 2019 | |
| Optos, INC. | $62.75 | 2022 | |
| Bausch & Lomb Americas INC. | $47.37 | 2022 | |
| Kala Pharmaceuticals, INC. | $40.78 | 2019 | |
| Coopervision INC. | $36.09 | 2019 | |
| Abb Con-Cise Optical Group LLC | $19.26 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.47 | 2022 | |
| Shire North American Group INC | $14.93 | 2019 | |
| Lkc Technologies, INC. | $14.42 | 2025 | |
| Sight Sciences, INC. | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.